JezK
Edit File: 1595665250.M956502P3095933.mocha3025.mochahost.com,S=25863,W=26646:2,S
Return-Path: <pharmacy@jack.ngo> Received: from mocha3025.mochahost.com by mocha3025.mochahost.com with LMTP id EBYbN2LrG199PS8AaMJ/gg (envelope-from <pharmacy@jack.ngo>); Sat, 25 Jul 2020 04:20:50 -0400 Return-path: <pharmacy@jack.ngo> Envelope-to: ahmad@jack.ngo, finance.manager@jack.ngo, hadi@jack.ngo, hafiz@jack.ngo, takal@jack.ngo Delivery-date: Sat, 25 Jul 2020 04:20:50 -0400 Received: from [103.215.211.27] (port=49950 helo=LogisticManager) by mocha3025.mochahost.com with esmtpsa (TLSv1.2:ECDHE-RSA-AES256-GCM-SHA384:256) (Exim 4.92) (envelope-from <pharmacy@jack.ngo>) id 1jzFQG-00D6U8-2c; Sat, 25 Jul 2020 04:20:50 -0400 From: <pharmacy@jack.ngo> To: <ahmad@jack.ngo> Cc: "'Sardar Wali Takal'" <takal@jack.ngo>, <finance.manager@jack.ngo>, "'hafiz'" <hafiz@jack.ngo>, "'hadi'" <hadi@jack.ngo> References: <01a301d651fc$887e8610$997b9230$@jack.ngo> <20200707134947.Horde.lF5XtkGwPHxHYHiJ98choTx@www.jack.ngo> <000001d65514$7d851970$788f4c50$@jack.ngo> <004801d65515$724ef660$56ece320$@jack.ngo> In-Reply-To: <004801d65515$724ef660$56ece320$@jack.ngo> Subject: RE: Medicine supply status and alternative options Date: Sat, 25 Jul 2020 12:50:47 +0430 Message-ID: <000701d6625c$82d133f0$88739bd0$@jack.ngo> MIME-Version: 1.0 Content-Type: multipart/mixed; boundary="----=_NextPart_000_0008_01D66282.3AC88A60" X-Mailer: Microsoft Outlook 15.0 Thread-Index: AQL5tYsxtWkO5byQlxS+niqw/iAN/QIOCciUAiidKTsBYQBNSaakfVug Content-Language: en-us This is a multipart message in MIME format. ------=_NextPart_000_0008_01D66282.3AC88A60 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Dear Dr Sahib Noor Ahmad Here is the status of the BPHS supply in Kunduz. We will purchase the = pending items by RFQ from market, though we issued warning letters to = supplier, but they are not able to supply, the possible reason could be = market price fluctuation and high demand for IV infustions. With best regards Pharmacy & Procurement Team -----Original Message----- From: ahmad@jack.ngo [mailto:ahmad@jack.ngo]=20 Sent: Wednesday, July 8, 2020 3:19 PM To: pharmacy@jack.ngo Cc: 'Sardar Wali Takal' <takal@jack.ngo>; finance.manager@jack.ngo; = 'hafiz' <hafiz@jack.ngo>; 'hadi' <hadi@jack.ngo> Subject: RE: Medicine supply status and alternative options Dear Dr. Sahib Bashir,=20 It is well received and let me to check it with team then will come back = to you.=20 With best regards,=20 =20 =20 Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D MD,PGD (Leadership) PGD (NMD), PMP = Program Manager=20 Just for Afghan Capacity and Knowledge =D8=A8=D9=84=D9=86=D8=AF = =D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 = =D9=88 =D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C = =D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9) =20 Address: First Street of Karta-e-Chahar, Kabul Afghanistan Behind AWCC = Main Office, House # 08 Ph: +93 792410436 - 0783504353 Email: ahmad@jack.ngo Website:www.jack.ngo =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D This e-mail and any files transmitted with it may contain privileged or = confidential information. It is solely for use by the individual for = whom it is intended, even if addressed incorrectly. If you received this = e-mail in error, please notify the sender; do not disclose copy, = distribute, or take any action in reliance on the contents of this = information; and delete it from your system. Any other use of this = e-mail is prohibited. The views expressed herein are those of the author = and do not necessarily reflect the views or policies of jack = (Afghanistan). Electronic transmissions may be recorded and = monitored.For Verification Please Read the Barcode Reader. =20 =EF=81=90 Every 3000 sheets of paper costs us a tree. Please don't print = this e-mail unless you really need to -----Original Message----- From: pharmacy@jack.ngo [mailto:pharmacy@jack.ngo] Sent: Wednesday, July 8, 2020 3:13 PM To: ahmad@jack.ngo Cc: 'Sardar Wali Takal'; finance.manager@jack.ngo; 'hafiz'; 'hadi' Subject: RE: Medicine supply status and alternative options Hello Again, In case the table is not visible in outlook, I have attached in excel = that need your green light. Best regards Bashir -----Original Message----- From: pharmacy@jack.ngo [mailto:pharmacy@jack.ngo] Sent: Tuesday, July 7, 2020 10:20 PM To: ahmad@jack.ngo Cc: 'Sardar Wali Takal' <takal@jack.ngo>; finance.manager@jack.ngo; = 'hafiz' <hafiz@jack.ngo>; 'hadi' <hadi@jack.ngo> Subject: Re: Medicine supply status and alternative options Dear Dr Sahib Noor Ahmad, Please let us know when you reached to conclusion that we can push = suppliers to supply urgently. BR Bashir Quoting pharmacy@jack.ngo: > Dear Dr Sahib Noor Ahmad, > > As we have in the supply process of current quarter , there are some=20 > items which is not available with the brand with supplier and the=20 > suppliers proposed alternative brands, we need your green light to = proceed. > > From financial point of view, our budget will be saved more roughly by > 650,000 AFN from alternative brand choice. > > From quality point of view, both alternative and initial selected=20 > brands are complying with MoPH requirement. > > > > > Number > > Item name > > Unit > > Quantity > > Brand name in contract > > Unit price > > Total price > > Alternative brand > > Unit price of alternative brand > > Total price of alternative brand > > Status > > > 1 > > Doxycycline Capsules 100 mg > > Capsule > > 100000 > > Merck Pakistan > > 3.335 > > 333,500.00 > > Shandong, China > > 2,88 > > 288000 > > Pending our GL to supplier > > > 2 > > Ampicillin 1 g vial > > Vial > > 14000 > > Stalion, Pakistan > > 16.5 > > 198000 > > Shandong, China( > > 18( 1 vial of 500 mg =3D9 AFN) > > 252000 > > Pending our GL to supplier > > > 3 > > Ibuprofen 400 mg tablets > > Tablet > > 200000 > > Abott, Pakistan > > 1.4 > > 280000 > > Arbro, India > > 1 > > 200000 > > Pending our GL to supplier > > > 4 > > Erythromycin 250 mg > > Tablet > > 150000 > > Indus pharma, Pakistan > > 4.6 > > 690000 > > RPL, India > > 3.2 > > 480000 > > GL by Pharmacy, in Kunduz warehouse > > > 5 > > Multivitamin and mineral tables > > Tablet > > 300000 > > Kocilac, Turkey > > 0.75 > > 225000 > > Maiden/Arbro, India > > 0.345 > > 77625 > > GL by Pharmacy, in Kunduz warehouse > > > 6 > > Chloramphenicol 250mg Cap > > > > Capsules > > 20000 > > Pliva, Pakistan > > 1.84 > > 36800 > > Chines brand > > 1.84 > > 36800 > > GL by Pharmacy, in Kunduz warehouse > > > 7 > > Gentamycin sulfate 10mg/ml in 2ml inj > > Amp > > 6000 > > Midcare, Pak > > 5.75 > > 34500 > > ASCC/China > > > > 5.75 > > 34500 > > GL by Pharmacy, in Kunduz warehouse > > > 8 > > Metoclopramide hcl 10mg tab > > > > Tabs > > 20000 > > > > GSK/Pakistan > > 0.69 > > 13800 > > Dentafil, Uzbekistan > > 0.69 > > 13800 > > GL by Pharmacy, in Kunduz warehouse > > > Also the following items got short in market and still not supplied=20 > from suppliers, there are two options, waiting 1 week possibly to be=20 > released from customs, 2 purchase directly from other suppliers in=20 > higher prices from current suppliers bank guarantee > > > > > 1 > > Glucose 4%+Sodium Chloride 0.18% 500ml IV infusion with set > > Bag > > 4000 > > Unisol/ Pakistan > > 36.8 > > 147,200.00 > > > > > > > > Pending with supplier, we give them final deadline by this week > > > 2 > > Glucose 5% 500ml IV infusion with set > > Zeesol > > 6,000 > > Zeasol/Pakistan > > 28 > > 168,000 > > > > > > > > Pending with supplier, we give them final deadline by this week > > > 3 > > Ringer lactate iv 500ml IV infusion ( with set) > > Paksol > > 12,000 > > Paksol/Pakistan > > 28 > > 336,000 > > > > > > > > Pending with supplier, we give them final deadline by this week > > > Also the following items are short in market, they are in category non = > vital, and we will cancel them > > > 1 > > Nystatin 500 mg tablet > > > > > > > > > > > > > > > > > > To be cancelled( 100 mg we have stock) > > > 2 > > Hemuce strips > > > > > > > > > > > > > > > > > > 50 units ordered, and 40 will be cancelled > > > 3 > > Sodium bicarbonate > > > > > > > > > > > > > > > > > > To be cancelled( limited usage) > > > 4 > > Liocaine gel > > > > > > > > > > > > > > > > > > To be cancelled( limited usage) > > > > > > With best regards > > Bashir ------=_NextPart_000_0008_01D66282.3AC88A60 Content-Type: application/vnd.openxmlformats-officedocument.spreadsheetml.sheet; name="Alternative brands.xlsx" Content-Transfer-Encoding: base64 Content-Disposition: attachment; filename="Alternative brands.xlsx" UEsDBBQABgAIAAAAIQBBN4LPbgEAAAQFAAATAAgCW0NvbnRlbnRfVHlwZXNdLnhtbCCiBAIooAAC AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACs VMluwjAQvVfqP0S+Vomhh6qqCBy6HFsk6AeYeJJYJLblGSj8fSdmUVWxCMElUWzPWybzPBit2iZZ QkDjbC76WU8kYAunja1y8T39SJ9FgqSsVo2zkIs1oBgN7+8G07UHTLjaYi5qIv8iJRY1tAoz58Hy TulCq4g/QyW9KuaqAvnY6z3JwlkCSyl1GGI4eINSLRpK3le8vFEyM1Ykr5tzHVUulPeNKRSxULm0 +h9J6srSFKBdsWgZOkMfQGmsAahtMh8MM4YJELExFPIgZ4AGLyPdusq4MgrD2nh8YOtHGLqd4662 dV/8O4LRkIxVoE/Vsne5auSPC/OZc/PsNMilrYktylpl7E73Cf54GGV89W8spPMXgc/oIJ4xkPF5 vYQIc4YQad0A3rrtEfQcc60C6Anx9FY3F/AX+5QOjtQ4OI+c2gCXd2EXka469QwEgQzsQ3Jo2PaM HPmr2w7dnaJBH+CW8Q4b/gIAAP//AwBQSwMEFAAGAAgAAAAhALVVMCP0AAAATAIAAAsACAJfcmVs cy8ucmVscyCiBAIooAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAACskk1PwzAMhu9I/IfI99XdkBBCS3dBSLshVH6ASdwPtY2jJBvdvyccEFQa gwNHf71+/Mrb3TyN6sgh9uI0rIsSFDsjtnethpf6cXUHKiZylkZxrOHEEXbV9dX2mUdKeSh2vY8q q7iooUvJ3yNG0/FEsRDPLlcaCROlHIYWPZmBWsZNWd5i+K4B1UJT7a2GsLc3oOqTz5t/15am6Q0/ iDlM7NKZFchzYmfZrnzIbCH1+RpVU2g5abBinnI6InlfZGzA80SbvxP9fC1OnMhSIjQS+DLPR8cl oPV/WrQ08cudecQ3CcOryPDJgosfqN4BAAD//wMAUEsDBBQABgAIAAAAIQCBPpSX8wAAALoCAAAa AAgBeGwvX3JlbHMvd29ya2Jvb2sueG1sLnJlbHMgogQBKKAAAQAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAACsUk1LxDAQvQv+hzB3m3YVEdl0LyLsVesPCMm0KdsmITN+9N8bKrpdWNZLLwNvhnnv zcd29zUO4gMT9cErqIoSBHoTbO87BW/N880DCGLtrR6CRwUTEuzq66vtCw6acxO5PpLILJ4UOOb4 KCUZh6OmIkT0udKGNGrOMHUyanPQHcpNWd7LtOSA+oRT7K2CtLe3IJopZuX/uUPb9gafgnkf0fMZ CUk8DXkA0ejUISv4wUX2CPK8/GZNec5rwaP6DOUcq0seqjU9fIZ0IIfIRx9/KZJz5aKZu1Xv4XRC +8opv9vyLMv072bkycfV3wAAAP//AwBQSwMEFAAGAAgAAAAhACmxtQlAAgAAmQQAAA8AAAB4bC93 b3JrYm9vay54bWysVEtv2zAMvg/YfxB0T/yo3aZG7KJNMqzAUHRdH5dcFJmOhejhSfKSYNh/H23P W7deOmwXk5KpT+T3kZpfHJQkX8A6YXROo2lICWhuSqG3OX24fzeZUeI80yWTRkNOj+DoRfH2zXxv 7G5jzI4ggHY5rb1vsiBwvAbF3NQ0oPFPZaxiHpd2G7jGAitdDeCVDOIwPA0UE5oOCJl9DYapKsFh aXirQPsBxIJkHtN3tWjciKb4a+AUs7u2mXCjGoTYCCn8sQelRPHsequNZRuJZR+idERG9wW0Etwa Zyo/RahgSPJFvVEYRNFQcjGvhITHgXbCmuaGqe4WSYlkzq9K4aHM6SkuzR5+27Btc9UKiX+jJIlD GhQ/pbi1pISKtdLfowgjPAamJ3Ecd5FY1KX0YDXzsDDaI4c/2P9XvnrsRW1QHXIHn1thAZuio62Y 45fxjG3cLfM1aa3M6SJbPzgsf7200yuGyllyWStWivUS3M6bZv0xJnEYh+tntLOXmv4F8Yx3DARI wZDm4P9JRzHvmvpRwN79IrZbksOT0KXZ5xRH5PjM3/fbT6L0NVIdpagJGfbeg9jWPqez06jXKXgG 3Y8BXtFbonv5P3WjEeG8dfa6U5gSmwl07HUZ9dmPxziTHOXuTB+YxmnUR8DBf3C+mKNFpkVOv0ZJ eHkWnieTcHWSTpLZeTyZJSfxZJEs41V6tlqurtJv/7e5UfBsfB+6LGtm/b1lfIevyh1UKDg2+1AQ 5olCjFkH46niOwAAAP//AwBQSwMEFAAGAAgAAAAhAEU1xgD9AgAASAcAABQAAAB4bC9zaGFyZWRT dHJpbmdzLnhtbJSVbW/TMBDH3yPxHU6RJg1RlnZsaENtp21oMAkmYA9Ie+c618SqH4J9btdvzznZ xkg6AS/yInf2/e/s353HR3dGwxJ9UM5OstHOMAO00hXKlpPs+urszUEGgYQthHYWJ9kaQ3Y0ffli HAIB77VhklVE9fs8D7JCI8KOq9GyZ+68EcS/vsxD7VEUoUIko/Pd4fBdboSyGUgXLU2yvb0MolU/ I562hreH2XQc1HRM04toZujHOU3HebK01nNCA1YY7DquraKu7VsUlhStu/YTz4U1UUBZzsWSF7K3 O0WE2ivZ07pyJPRm17Em9FaQWiLMksymPNut4OYg/rb8idQ/rb8kQTF0RT+4u7VcS60swqmoQ9QY YDQcgim7S+/dXfMX9HIBX8VCJSq63suKK3W2HMBppazouo9NraTSLA8jKGGphO4uudlg41o04zn4 V9ntbtDRwTYLJrl0dvtNvTA5hOOzi1e9HHVwQBXC3GntVtwHoJi1AKUjCJXzlFgxwi+QIOETiCsC m7yxrrXCAubemYc/HwYpnEcQ/NHKgauJq2HzSihK8UewQlxA7UJQM70GcjBD8KhRhIdoMgZyhjft Qh29rNgDhfIoiTc0ei6p/FZNWVaqTLaG3dCuktF7tI+5+gAzYRdQRsGQEvYQ/6ijdKy1t/X6kqdC NHyz2nlVIAx3Rgdb6TR5gpzfsN48pikCK0UVBOz10YnoQcatFZzOn73YB/X9/9G5ReSg3Xu95cNk qefI/c4XwUeluf8FIajlhsK2H0vrUcNhN2i21mc1j59DLZHSQa2BaN0wlEYV51g6v2bsLHPN/TFo WFwhp8g0SmEl6sSd6Z7DxZobl7F7aAMSM92/q6sGwTaMxoLbp20aFqgEjzSGUS56p/AJTZTJ6VXd mz37wzTiKYDzBbdD0Wa8N2wzZuAf1XpTpQVvpqTwM8dDdcMgTh3zJF2tDHdtATGIEnt5flZO8vOD UGKPkx9to2rnFqk3+RX7Yzjf9/iT9yjnl3D6CwAA//8DAFBLAwQUAAYACAAAACEAO20yS8EAAABC AQAAIwAAAHhsL3dvcmtzaGVldHMvX3JlbHMvc2hlZXQxLnhtbC5yZWxzhI/BisIwFEX3A/5DeHuT 1oUMQ1M3IrhV5wNi+toG25eQ9xT9e7McZcDl5XDP5Tab+zypG2YOkSzUugKF5GMXaLDwe9otv0Gx OOrcFAktPJBh0y6+mgNOTkqJx5BYFQuxhVEk/RjDfsTZsY4JqZA+5tlJiXkwyfmLG9Csqmpt8l8H tC9Ote8s5H1Xgzo9Uln+7I59Hzxuo7/OSPLPhEk5kGA+okg5yEXt8oBiQet39p5rfQ4Epm3My/P2 CQAA//8DAFBLAwQUAAYACAAAACEAi4JuWJMGAACOGgAAEwAAAHhsL3RoZW1lL3RoZW1lMS54bWzs Wc+LGzcUvhf6Pwxzd/xrZmwv8QZ7bGfb7CYh66TkqLVlj7KakRnJuzEhUJJjoVCall4KvfVQ2gYS 6CX9a7ZNaVPIv9AnzdgjreVumm4gLVnDMqP59PTpvTffkzQXL92NqXOEU05Y0narFyqug5MRG5Nk 2nZvDgelputwgZIxoizBbXeBuXtp+/33LqItEeEYO9A/4Vuo7UZCzLbKZT6CZsQvsBlO4NmEpTES cJtOy+MUHYPdmJZrlUpQjhFJXCdBMZi9NpmQEXaG0qS7vTTep3CbCC4bRjTdl6ax0UNhx4dVieAL HtLUOUK07cI4Y3Y8xHeF61DEBTxouxX155a3L5bRVt6Jig19tX4D9Zf3yzuMD2tqzHR6sBrU83wv 6KzsKwAV67h+ox/0g5U9BUCjEcw046Lb9Lutbs/PsRoou7TY7jV69aqB1+zX1zh3fPkz8AqU2ffW 8INBCF408AqU4X2LTxq10DPwCpThgzV8o9LpeQ0Dr0ARJcnhGrriB/VwOdsVZMLojhXe8r1Bo5Yb L1CQDavskkNMWCI25VqM7rB0AAAJpEiQxBGLGZ6gEWRxiCg5SImzS6YRJN4MJYxDc6VWGVTq8F/+ PHWlPIK2MNJ6S17AhK81ST4OH6VkJtruh2DV1SAvn33/8tkT5+WzxycPnp48+Onk4cOTBz9mtoyO OyiZ6h1ffPvZn19/7Pzx5JsXj76w47mO//WHT375+XM7ECZbeOH5l49/e/r4+Vef/v7dIwu8k6ID HT4kMebOVXzs3GAxzE15wWSOD9J/1mMYIWL0QBHYtpjui8gAXl0gasN1sem8WykIjA14eX7H4Lof pXNBLCNfiWIDuMcY7bLU6oArcizNw8N5MrUPns513A2EjmxjhygxQtufz0BZic1kGGGD5nWKEoGm OMHCkc/YIcaW2d0mxPDrHhmljLOJcG4Tp4uI1SVDcmAkUtFph8QQl4WNIITa8M3eLafLqG3WPXxk IuGFQNRCfoip4cbLaC5QbDM5RDHVHb6LRGQjub9IRzquzwVEeoopc/pjzLmtz7UU5qsF/QqIiz3s e3QRm8hUkEObzV3EmI7sscMwQvHMypkkkY79gB9CiiLnOhM2+B4z3xB5D3FAycZw3yLYCPfZQnAT dFWnVCSIfDJPLbG8jJn5Pi7oBGGlMiD7hprHJDlT2k+Juv9O1LOqdFrUOymxvlo7p6R8E+4/KOA9 NE+uY3hn1gvYO/1+p9/u/16/N73L56/ahVCDhherdbV2jzcu3SeE0n2xoHiXq9U7h/I0HkCj2lao veVqKzeL4DLfKBi4aYpUHydl4iMiov0IzWCJX1Ub0SnPTU+5M2McVv6qWW2J8Snbav8wj/fYONux Vqtyd5qJB0eiaK/4q3bYbYgMHTSKXdjKvNrXTtVueUlA9v0nJLTBTBJ1C4nGshGi8Hck1MzOhUXL wqIpzS9DtYziyhVAbRUVWD85sOpqu76XnQTApgpRPJZxyg4FltGVwTnXSG9yJtUzABYTywwoIt2S XDdOT84uS7VXiLRBQks3k4SWhhEa4zw79aOT84x1qwipQU+6Yvk2FDQazTcRaykip7SBJrpS0MQ5 brtB3YfTsRGatd0J7PzhMp5B7nC57kV0CsdnI5FmL/zrKMss5aKHeJQ5XIlOpgYxETh1KInbrpz+ KhtoojREcavWQBDeWnItkJW3jRwE3QwynkzwSOhh11qkp7NbUPhMK6xPVffXB8uebA7h3o/Gx84B nac3EKSY36hKB44JhwOgaubNMYETzZWQFfl3qjDlsqsfKaocytoRnUUoryi6mGdwJaIrOupu5QPt Lp8zOHTdhQdTWWD/ddU9u1RLz2miWdRMQ1Vk1bSL6Zsr8hqroogarDLpVtsGXmhda6l1kKjWKnFG 1X2FgqBRKwYzqEnG6zIsNTtvNamd44JA80SwwW+rGmH1xOtWfuh3OmtlgViuK1Xiq08f+tcJdnAH xKMH58BzKrgKJXx7SBEs+rKT5Ew24BW5K/I1Ilw585S03XsVv+OFNT8sVZp+v+TVvUqp6XfqpY7v 16t9v1rpdWv3obCIKK762WeXAZxH0UX+8UW1r32AiZdHbhdGLC4z9YGlrIirDzDV2uYPMA4B0bkX 1AateqsblFr1zqDk9brNUisMuqVeEDZ6g17oN1uD+65zpMBepx56Qb9ZCqphWPKCiqTfbJUaXq3W 8RqdZt/r3M+XMTDzTD5yX4B7Fa/tvwAAAP//AwBQSwMEFAAGAAgAAAAhANUMxlptAwAA8Q8AAA0A AAB4bC9zdHlsZXMueG1s7Fdbb9MwFH5H4j9Efs+StE1pqyQTXRcJCSakDYlXN3Faa75EjjtaEP+d Yztpg0ZhDBhF4qW1j+3vfOeSc+zkfMuZd0dUQ6VIUXQWIo+IQpZUrFL07ib3J8hrNBYlZlKQFO1I g86z58+SRu8YuV4Toj2AEE2K1lrXsyBoijXhuDmTNRGwUknFsYapWgVNrQguG3OIs2AQhuOAYyqQ Q5jx4iEgHKvbTe0XktdY0yVlVO8sFvJ4MXu1ElLhJQOq22iEiw7bTu7Bc1oo2chKnwFcIKuKFuQ+ y2kwDQApSyopdOMVciN0igYAbTTMboX8IHKzBA5sd2VJ89G7wwwkEQqypJBMKk+DZ4CYlQjMidtx gRldKmq2VZhTtnPigRFYZ7b7OAXTjDAwPByb36WnhbR/DUBTxnqGOkGWgMM1USKHVa8d3+xqsEhA bjhmsPTD3SuFd9Eg7h0IrMIsWUpVQi52Ln4B3nSiLGGk0mC7oqu1+deyht+l1BoClyUlxSspMDPe 6U70T0IOQ7qmiJOSbjjAuoBQUZItKVM0Hlk2Rkmr44EnLB9L54EHgHjH+4EnnJE/trHzzr/H/Ami s0+WU3H6nyL08750X9PJpO9fpNOWDiiABWHs2pSM99W+Gpnavq08seE516+gaECvNJW4G0Lpa4eu 8riJqUh9NIfdhw0fhettq72CY6wiIPgtViDvTnu4rtnOdC/Tl9xsbqvwYf6S0ZXgxG3JEmhXbmru DZoWpssVsEoU8j4oXN+QrQUzlm+r4z47xs401ta2E2Q3PGl2o7/HDlR3X8OxyN5jd7XhS6Jye0U8 5NvTZSME85/j3Ks6x/wcn3SOjv9XH3vZNLXRtgZoBr2O81W/2XcOz7wXUnRlPhXWc+ByQ5mm4hu9 BjDL7aF7hUanNi8j29f2WiCdSlLhDdM3+8UUHcZv7I0ZanK76y29k9pCpOgwfm2u5dHY6IDq/7qB WzT8extFU/Tpcv5iurjMB/4knE/80ZDE/jSeL/x4dDFfLPJpOAgvPvcear/wTLPPSWg50WjWMHjM qdbYlvz1QZai3sTRt1EB2n3u08E4fBlHoZ8Pw8gfjfHEn4yHsZ/H0WAxHs0v4zzucY8fxz0Kgyhy b2FDPp5pygmjootVF6G+FIIE0+8YEXSRCA5v9ewLAAAA//8DAFBLAwQUAAYACAAAACEAJhmV9EIF AADtFQAAGAAAAHhsL3dvcmtzaGVldHMvc2hlZXQxLnhtbLRYXY+qSBB932T/A+H9goA6atSbXD9R Ntns3Y9nBlslA7YLPV//fqu7BekqnEwy7jyMejh9qqlTVDc9/v6WZ9YLK8qUnya253Rsi50SvktP h4n915/LbwPbKkV82sUZP7GJ/c5K+/v011/Gr7x4Ko+MCQsUTuXEPgpxHrlumRxZHpcOP7MTXNnz Io8F/CwObnkuWLxTg/LM9TudvpvH6cnWCqPiMxp8v08TNufJc85OQosULIsFzL88pueyUsuTz8jl cfH0fP6W8PwMEo9plop3JWpbeTIKDydexI8Z3Peb142TSlv9IPJ5mhS85HvhgJyrJ0rveegOXVCa jncp3IFMu1Ww/cT+4Y0iL7Dd6Vgl6O+UvZaN75aIH3+yjCWC7cAn25L5f+T8SRJDgDogWSqClIwT kb6wGcuyiR31wMJ/VRD4CgHcOkLzexVtqRz7vbB2bB8/Z+IP/rpm6eEoICwoqXsf7d7nrEzAAQjs +Eo14RlIwH8rT6GUAshg/KY+X9OdOMI337aS51Lw/B8NeHIy9QAoNDUAPi8DvMDxup0+yH80bngZ B5+XcT6k54NAHsxDRZJfqrn1nEGv1+0PHlqDufrmVN7msYin44K/WlCwEKk8x7L8/ZGU01lypIo4 psnTDy7T1po15fVFBkYSmX7nkzKQQzmVH1JEBYOQJVTDy7Qzdl/A4uTCmGkG/K8ZnsmYU4ZvMhaU EZiMJWV0TcaKMnomY00ZfZMRUsaDydhQxsBkbCljaDKiloxdk+qCe3UlQL0TC/2HqhDrJ+gzdVEZ KiXlAyStREbN9LVu00rsZQsFm1lRVISO/ENetmggu1dNjcAJAmylvt5TdxHAZRwjbImBCmbTjOE7 A+yjcXkwILcR0RDBVcOwETJ6bxulZGUjMmCmrxk2ovzNWyjoWVhUFGVjl7rYIoEelpUh0Xewicbl Ic1w2BICubRpoaDHbdsM4/dgh4DqMaIat4yUix7uzF98HqXkxIZnum6fPu6wmjJQC5tsynMMLDCw xMAKA2sMhBjYYGCrgWE9D7UHmNhdtfw321b//mmSkrfalr7WrHcft60WCm5bFUXWe0u5tyjgptVU CPrOw7D5h56NtSbrDuZ1H6As0VpUqcntjHR9g4EtBiI6x1uFDPV270KWkrc6kr5mOIS68byFgvrF QlP6qun3aUNqUUA9bVVRpMc+aiXrprzXb2lH1ejaEQxsMRDROd1yRL4S3bm1SMnKEVSrM33NcARV 6LyFglK20BTtiEc767JFAnXnVUVptaSpHwTU87AaXVuCgS0GIjqnW5bA5v/elkhJs9sHuNtrSqPb Y2CBgSUGVhhYYyDEwAYDWwxEGlDt39jdePB6f+88KU1Zu5WxswvSrNgAd/maU41aEGRJkBVB1gQJ CbIhyJYgUducr8uOmcS2l74vbi08qWkmUSNGElFnmF9GqVVdLTwLgiwJsiLImiAhQTYE2RIkqpHr Dim4Lh5mEtteeb+aRP221qxEjRhJxPtr+doOqW8mESNLwlkRZE2QkCAbgmwJEtVII4nXxdFM4v/w 0glnULgSW96e8AJ0GdVMYjWqesCXhLMiyJogIUE2BNkSRJ6kaVM/SKI+BtPHOTkrDuq4rLQS/iyP tXzYu9To5YhuOILOCveD8d4INtzyYO0qMx2f4wP7LS4O6am0MrZXJ2Wwxyj0URoc7sB7BD/L8zN5 WvTIBRyMVb+OcE7KYCPZceA+9pyL6gcEkbo/mXg+W7xI4QROHX1O7DMvRBGnAiKMUjgPLMKdOl9z 64Pa6X8AAAD//wMAUEsDBBQABgAIAAAAIQDKy4EmTwEAAHsCAAARAAgBZG9jUHJvcHMvY29yZS54 bWwgogQBKKAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACMklFLwzAUhd8F/0PJe5u0o26E tgOVPTkQrUx8C8ndFmzSkkS7/XvTdquVKfiYnHO/nHtItjyoKvgEY2WtcxRHBAWgeS2k3uXopVyF CxRYx7RgVa0hR0ewaFlcX2W8obw28GjqBoyTYANP0pbyJkd75xqKseV7UMxG3qG9uK2NYs4fzQ43 jL+zHeCEkBuswDHBHMMdMGxGIjohBR+RzYepeoDgGCpQoJ3FcRTjb68Do+yvA70ycSrpjo3f6RR3 yhZ8EEf3wcrR2LZt1M76GD5/jF/XD8/9qqHUXVccUJEJTrkB5mpTrJ/KoJvZSJ2smK864rXK8MTR tVkx69a++K0EcXv8a+jS6F/qFxueAxH4qHRY7KxsZnf35QoVCUlISOYhWZQxobOUpvO3LseP+S76 cKFOaf5BTNKSLGgc0zSdEM+AIsMX36X4AgAA//8DAFBLAwQUAAYACAAAACEAPwdqDCMIAAAMNAAA JwAAAHhsL3ByaW50ZXJTZXR0aW5ncy9wcmludGVyU2V0dGluZ3MxLmJpbuxazY8bZxl/NmnDNkVV iVBVSgURQghVXeTdLmkSRRB77c168ReecZNWlZZZz2t72NmZ0czrsBs+lEOFOCAEtIIeOOTQC1IP UbVCOVTwD1QIVRw4ICFx4MCJU1UhBPyed2Y8r3dtxwsKG5UZazzv730+3uf5vZ/j3Q1q0XmqkUUR CQppE98SNXVaV5I6reDzIi2hZoVeoGUavxYeOX3mj1R4Ye03C6cWaIH+etZftPE8vXAD+BTdOHUa qKa8StXCIQf/AVxIbPh5Cvc5FP6F61rVWNXdlauNzudo8Yy9+N5zj31t8auzmlqCMPXLeqnv2IYz y66srNf+93nlHk6WgeP05uIZIqNubnLET9KHj36bCrRNPcyjL1MXpQJmzCXMl0uYMUu0ivoLqF1S kgLQEup7qBeouYD5dQmfF1F/ib4Lj1UvGMqS41EnEq3Q8aQIDSGl4/WpXTHKtRp1PCcUEZdqftdy BVW8vutEgy0IpLC3DGlJEZEhYd2P1txhBB8FqpaNrWKp2THNYmmrUaxXDmksZxpbG62ttWbr5Xb1 2oa5TCqMrw8t15H7tOH0Bxxb2BaR7w6l43uUFdetSC6vFApaFV0oFOzAobLfHe4KTzaGrsuxBcaO EwScFxeKPQS55iNdT9Ka7/ph3bcF1X3P7w5Cf1dQywpAhXNLUK1impU2NUMHypaKoNVsm+1i1aS6 sB3L3A8EFYfSN4QrujKrSwitgigH6dyKjcvNRoXKw8AVe/RSpW1W14o1qlseMk5qY2A4u0pn099e d52gZfVFJ6Ce5UYiyw41y9ToBCU/tEUYUbPXA4EiSkMto/O6MWtgUpZ8Kf1dzthFr1GzgTz7ou1z Hy5fLFDDV2VmGc2yrMl+0XeWZ1uhPWq40gVVirPxgDb2t0PHbqNfYKUD5iez9qxtV5ScftmSFgeT xHikpumNbKoeRoHkkCKEqaO0q0uu5e0YAyFkZa8rAs56mUqi54diVBHbz7BYmW2hOldzfxinnsfr V+KBMrJbyZhII+1EyIyMQHSdniPsOE7+RlbdHVPsSWTtCbrWqSZTTU2gjlHZahVblfaWUX0FwyoZ 9Wv+TRGuhxjgsFJgXFSCzyOSKs9+V1g3E4YzxHFcxxAJd61wh1QwY1UtxCh4ttEavtDzY9KatS94 caAmgnKt/XFpnHjRdbOUW74aPsujmLFA2eygwVOH9QysRKMKBgIDPxKy6Dp9Tw/ko7PTvfcc0Uur 5Xq6d7z8p/rrzyK9N54g+gqed1/9++M/eX1n8+7ZzzZ+tf/zX+6h/h+niR6B7PahMwXXQazq2R/j p3G/hjvFX0D5Bxouo/xDDdso/xg3mqDvJbI3NPkByp+Es9TfX7gNgFT/GZSf1XAJ5V9oeMByHLpS +x+xXMO/Br4DnPr7G/BbGn4K5c9DmMovA78FkPqzWY7EU/wm8BeBU/3fAj+v4Q+B39bweSg+/2hm bwK/reGfAt8FTv29j8KBhs/A1yr29lR+EfggwRzUTZZ/LJPfYbyYtfd71tfwOfi+B5z6awO/q+Hv A195LJPfY3mCub0PWH42ljM+j1iuPJ61d5XxxzP8TeCrGv4ZcFnD7wBvAHM8fHj+HXBNk3/AGIMw 5f8ycm1p+DawCZzaHwDf0OR/ZvxkZv8Ucn0VmPXP4S4DfyPB3EgILDX9O4w/kdm/D7yn4X8Cf0fD XwJXt4HZfwGyAfBrmvxN4INPaf6A7wGz/m3cT4DbdzX8GeArz8RyPKjA8gRzvBeB/5Dgq5BvMv50 rH8e2AZ+GgvANhXxNhXiRLeP2lfIx2cXpRaeEd6w+F2LqEEdCqiEupBsVXedHJQkDSZK+T3Ko/5U eVm9xw3U+1amtw7vPuywD+B5U7VTx7eNtiwy8H0LiPDGN4+eHuF8Fhvw7iDqASK4Xysm+AqmRlNF FgEN4acEjx68lZBBl3buk9k8Wnpe8+iPZzXLIsvpqNbRjLgmHh8ueLBUf0V4+z7aX/Nq6pnNazOe 3f2ssgwna07OMv7FQVIFMyNAzjiCIN8+Mp2e7/FsDmd+POujHMxnP87GLJvj81KhPYx3ofhy1Kzu gK2YNbw3YuzMaq+GWcOrz7hmC/OeZ5M8Bv/z2Uzjfz7r6fzPtp/M/ySb2fxPspif/0nWGf8m+ixU Y11OnNuz5TqvszUPr1Lcz7zu8+5wTa2k6V7E+0Af9RbGwRCx4WV7NBt534rH2HUl591rV2WA9xU8 d6G9oXa3aVotctVKLZQuj7Umfv/oqdEqSc9nekuzfYxnOt2LqXZlnieByoB31K7apWfZCMw7SSby 5OfsXFOt9WTXzXbY+7dQVD3DK/8sztMWeD931elhHu00nvmib6rR4aqxMl80fI5xMbrmiaUKFi1o O+B+Hv326ARhohU+B/XUOjad0aoaobybrMOWGZ2dd6ZvICaOTcw5LidZjo/GTcS8PZophFNfvEqn c4cZqEIeMxFB+q3kTIhfGXFu4vOhRFR88slsysCBinMPa4ivTpBwceIXjwB+f9Avnm+F5HM5yT/t u0lnmweVRIA4dugy+Ob1KD5D/i8JS9svqr700btC9WBXjeYHH0neDzHHeT+M85DPhwJWhXhdPsl1 6aTWhYdrPhjqN4Au1ucebn7z1c+iD8Me91GL4WHbF/J5wOtRPg/yuZ4zkDNw8gysIAR+f7tw5D/A 8t75f2GAfz/haz35pO/zXJePjfFRwHys5nMlXxxyBnIGcgZyBnIGcgZmMMB/M+E7v3IGHhQD6W9q /Jd7mfzlVW/r3wAAAP//AwBQSwMEFAAGAAgAAAAhANki2MyWAQAAIAMAABAACAFkb2NQcm9wcy9h cHAueG1sIKIEASigAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAnJJNb9swDIbvA/ofBN0b Oe02DIGsYkg69LBiAZJmZ02mY6GyJEiskezXj7aR1Gl72o0fL149pCjvDq1jHaRsgy/5fFZwBt6E yvp9yZ+2P66/cZZR+0q74KHkR8j8Tl19kusUIiS0kBlZ+FzyBjEuhMimgVbnGbU9deqQWo2Upr0I dW0NrIJ5acGjuCmKrwIOCL6C6jqeDfnouOjwf02rYHq+vNseIwEr+T1GZ41GmlI9WpNCDjWy+4MB J8W0KYluA+YlWTyqQoppKjdGO1iSsaq1yyDFa0E+gO6XttY2ZSU7XHRgMCSW7V9a2w1nf3SGHqfk nU5WeySsXjYmQ+xixqR+h/ScGwDMUpBgLA7hVDuN7Wc1HwQUXAp7gxGEGpeIW4sO8q96rRN+QDyf Eg8MI++Is+n5xjenfMPI9NIb72Voo/ZH9RhCoutgtwVb7VY03qkhf1r/nJ/iNqw0wmm7l0W5aXSC ij7kvP1zQT7QYpPrTZaN9nuoTpr3jf4WduPBq/mXWXFb0DdPalK8nrb6BwAA//8DAFBLAQItABQA BgAIAAAAIQBBN4LPbgEAAAQFAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1s UEsBAi0AFAAGAAgAAAAhALVVMCP0AAAATAIAAAsAAAAAAAAAAAAAAAAApwMAAF9yZWxzLy5yZWxz UEsBAi0AFAAGAAgAAAAhAIE+lJfzAAAAugIAABoAAAAAAAAAAAAAAAAAzAYAAHhsL19yZWxzL3dv cmtib29rLnhtbC5yZWxzUEsBAi0AFAAGAAgAAAAhACmxtQlAAgAAmQQAAA8AAAAAAAAAAAAAAAAA /wgAAHhsL3dvcmtib29rLnhtbFBLAQItABQABgAIAAAAIQBFNcYA/QIAAEgHAAAUAAAAAAAAAAAA AAAAAGwLAAB4bC9zaGFyZWRTdHJpbmdzLnhtbFBLAQItABQABgAIAAAAIQA7bTJLwQAAAEIBAAAj AAAAAAAAAAAAAAAAAJsOAAB4bC93b3Jrc2hlZXRzL19yZWxzL3NoZWV0MS54bWwucmVsc1BLAQIt ABQABgAIAAAAIQCLgm5YkwYAAI4aAAATAAAAAAAAAAAAAAAAAJ0PAAB4bC90aGVtZS90aGVtZTEu eG1sUEsBAi0AFAAGAAgAAAAhANUMxlptAwAA8Q8AAA0AAAAAAAAAAAAAAAAAYRYAAHhsL3N0eWxl cy54bWxQSwECLQAUAAYACAAAACEAJhmV9EIFAADtFQAAGAAAAAAAAAAAAAAAAAD5GQAAeGwvd29y a3NoZWV0cy9zaGVldDEueG1sUEsBAi0AFAAGAAgAAAAhAMrLgSZPAQAAewIAABEAAAAAAAAAAAAA AAAAcR8AAGRvY1Byb3BzL2NvcmUueG1sUEsBAi0AFAAGAAgAAAAhAD8HagwjCAAADDQAACcAAAAA AAAAAAAAAAAA9yEAAHhsL3ByaW50ZXJTZXR0aW5ncy9wcmludGVyU2V0dGluZ3MxLmJpblBLAQIt ABQABgAIAAAAIQDZItjMlgEAACADAAAQAAAAAAAAAAAAAAAAAF8qAABkb2NQcm9wcy9hcHAueG1s UEsFBgAAAAAMAAwAJgMAACstAAAAAA== ------=_NextPart_000_0008_01D66282.3AC88A60--